Literature DB >> 24340141

Positive influence of aspirin on coronary endothelial function: Importance of the dose.

Hiroki Teragawa1, Naoya Mitsuba, Ken Ishibashi, Satoshi Kurisu, Yasuki Kihara.   

Abstract

AIM: To investigate the effects of different doses of aspirin on coronary endothelial function.
METHODS: The study included 139 Japanese subjects (mean age, 60 years; 53 women) with angiographically normal coronary arteries. Patients were distributed into Group I (n = 63), who was administered aspirin and Group II (n = 76), the control, who were not administered aspirin. Group I was further divided into Group Ia (n = 50, low-dose aspirin, 100 mg) and Group Ib (n = 13, high-dose aspirin, 500 mg). After a routine coronary angiography, acetylcholine (ACh; 3 and 30 μg/min successively) and nitroglycerin (NTG) were infused into the left coronary ostium over 2 min. The change in the diameter of the coronary artery in response to each drug was expressed as the percentage change from baseline values.
RESULTS: The patient characteristics did not differ between the two groups. The change in coronary diameter in response to ACh was greater in Group I than in Group II (P = 0.0043), although the NTG-induced coronary vasodilation was similar between groups. ACh-induced dilation was greater in Group Ia than in Group Ib (P = 0.0231). Multivariate regression analysis showed that a low-dose of aspirin (P = 0.0004) was one of the factors associated with ACh-induced dilation at 30 μg/min.
CONCLUSION: In subjects with angiographically normal coronary arteries, aspirin only had a positive influence on coronary endothelial function at the low dose of 100 mg. This improvement of coronary endothelial function may be involved in the preventive effect of aspirin against future coronary events.

Entities:  

Keywords:  Acetylcholine; Aspirin; Coronary endothelial function; Quantitative coronary angiography

Year:  2013        PMID: 24340141      PMCID: PMC3857235          DOI: 10.4330/wjc.v5.i11.426

Source DB:  PubMed          Journal:  World J Cardiol


  31 in total

1.  Effects of various doses of aspirin on platelet activity and endothelial function.

Authors:  Takashi Furuno; Fumiyasu Yamasaki; Takeshi Yokoyama; Kyoko Sato; Takayuki Sato; Yoshinori Doi; Tetsuro Sugiura
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

Review 2.  Endothelial control of vascular tone in large and small coronary arteries.

Authors:  T F Lüscher; V Richard; M Tschudi; Z H Yang; C Boulanger
Journal:  J Am Coll Cardiol       Date:  1990-03-01       Impact factor: 24.094

3.  Leptin causes nitric-oxide independent coronary artery vasodilation in humans.

Authors:  Keiji Matsuda; Hiroki Teragawa; Yukihiro Fukuda; Keigo Nakagawa; Yukihito Higashi; Kazuaki Chayama
Journal:  Hypertens Res       Date:  2003-02       Impact factor: 3.872

4.  Magnesium causes nitric oxide independent coronary artery vasodilation in humans.

Authors:  H Teragawa; M Kato; T Yamagata; H Matsuura; G Kajiyama
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

5.  Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans.

Authors:  R Joannides; V Richard; W E Haefeli; A Benoist; L Linder; T F Lüscher; C Thuillez
Journal:  Hypertension       Date:  1997-12       Impact factor: 10.190

Review 6.  Endothelial dysfunction in human disease.

Authors:  H Drexler; B Hornig
Journal:  J Mol Cell Cardiol       Date:  1999-01       Impact factor: 5.000

7.  Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjects.

Authors:  E Magen; J R Viskoper; J Mishal; R Priluk; D London; C Yosefy
Journal:  J Hum Hypertens       Date:  2005-09       Impact factor: 3.012

8.  Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging.

Authors:  Hélène Bulckaen; Gaétan Prévost; Eric Boulanger; Géraldine Robitaille; Valérie Roquet; Cédric Gaxatte; Guillaume Garçon; Bruno Corman; Pierre Gosset; Pirouz Shirali; Colette Creusy; François Puisieux
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-25       Impact factor: 4.733

9.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

10.  The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

Authors:  Jill Belch; Angus MacCuish; Iain Campbell; Stuart Cobbe; Roy Taylor; Robin Prescott; Robert Lee; Jean Bancroft; Shirley MacEwan; James Shepherd; Peter Macfarlane; Andrew Morris; Roland Jung; Christopher Kelly; Alan Connacher; Norman Peden; Andrew Jamieson; David Matthews; Graeme Leese; John McKnight; Iain O'Brien; Colin Semple; John Petrie; Derek Gordon; Stuart Pringle; Ron MacWalter
Journal:  BMJ       Date:  2008-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.